Cargando…

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease

This article describes pathogenic concepts and factors, in particular glycolipid abnormalities, that create cell dysfunction and synaptic loss in neurodegenerative diseases. By phenocopying lysosomal storage disorders, such as Gaucher disease and related disorders, age- and dose-dependent changes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallett, Penelope J., Engelender, Simone, Isacson, Ole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647317/ https://www.ncbi.nlm.nih.gov/pubmed/31331333 http://dx.doi.org/10.1186/s12974-019-1532-2

Ejemplares similares

Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
por: Brekk, Oeystein R., et al.
Publicado: (2018)

Novel Results and Concepts Emerging From Lipid Cell Biology Relevant to Degenerative Brain Aging and Disease
por: Isacson, Ole, et al.
Publicado: (2019)

Progressive decline of glucocerebrosidase in aging and Parkinson's disease
por: Rocha, Emily M, et al.
Publicado: (2015)

Cell type-specific lipid storage changes in Parkinson’s disease patient brains are recapitulated by experimental glycolipid disturbance
por: Brekk, Oeystein Roed, et al.
Publicado: (2020)

Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
por: Wallom, Kerri-Lee, et al.
Publicado: (2021)

Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease Patients
por: Osborn, Teresia M., et al.
Publicado: (2020)

Fibroblasts from idiopathic Parkinson’s disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2
por: Thomas, Ria, et al.
Publicado: (2021)

Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson’s disease
por: Kumar, Manoj, et al.
Publicado: (2023)

AF-6 Protects Against Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson’s Disease
por: Basil, Adeline H., et al.
Publicado: (2017)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
por: Coleman, Colin, et al.
Publicado: (2022)

Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease
por: Davies, Sian E., et al.
Publicado: (2014)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2019)

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
por: Huebecker, Mylene, et al.
Publicado: (2020)

Loss of Lipid Carrier ApoE Exacerbates Brain Glial and Inflammatory Responses after Lysosomal GBA1 Inhibition
por: Connolly, Kyle J., et al.
Publicado: (2023)

Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1
por: Jacquemyn, Julie, et al.
Publicado: (2023)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
por: Marogianni, Chrysoula, et al.
Publicado: (2020)

A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)
por: Smith, Gaynor A., et al.
Publicado: (2015)

Brain Mitochondrial Dysfunction in Aging, Neurodegeneration, and Parkinson's Disease
por: Navarro, Ana, et al.
Publicado: (2010)

Mitochondrial lipids in neurodegeneration
por: Aufschnaiter, Andreas, et al.
Publicado: (2016)

Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration
por: Ayton, Scott, et al.
Publicado: (2014)

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
por: Paolini Paoletti, Federico, et al.
Publicado: (2021)

Association of p53 with Neurodegeneration in Parkinson's Disease
por: Luo, Qiang, et al.
Publicado: (2022)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
por: Surguchov, Andrei
Publicado: (2021)

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
por: Araújo, Bruna, et al.
Publicado: (2022)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Angiogenin and tRNA fragments in Parkinson’s disease and neurodegeneration
por: Prehn, Jochen H M, et al.
Publicado: (2020)

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice
por: Carlock, C, et al.
Publicado: (2017)

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice
por: Carlock, C, et al.
Publicado: (2017)

Single-neuron neurodegeneration as a degenerative model for Parkinson’s disease
por: Huenchuguala, Sandro, et al.
Publicado: (2023)

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
por: Seyfried, T. N., et al.
Publicado: (2018)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz, Marty, et al.
Publicado: (2016)

The cerebellum in Parkinson’s disease
por: Wu, Tao, et al.
Publicado: (2013)

Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration
por: Moll, Tobias, et al.
Publicado: (2020)

Beyond Host Defense: Deregulation of Drosophila Immunity and Age-Dependent Neurodegeneration
por: Arora, Srishti, et al.
Publicado: (2020)

Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease
por: Litteljohn, Darcy, et al.
Publicado: (2010)

Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
por: Lawn, Timothy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8g4qfhk5dfjp7p4acp52mlqb6n